Geneesmiddelenbeleid
This procedure is a report following general consultations on pharmaceutical policy in the Netherlands. It focuses on how the government manages the availability, pricing, and distribution of medicines to ensure public health and sustainable healthcare spending. The policy affects patients requiring medication, healthcare providers, and pharmaceutical companies operating within the Dutch market.
National vote coverage: Netherlands-only